Cera, the innovative digital-first home healthcare company, has successfully raised an impressive £316 million in its latest funding round, marking a significant milestone in its mission to reshape the healthcare landscape. With this infusion of capital, Cera plans to further expand its technology-enabled services, which currently cater to 30 million people across the UK and Germany, facilitating approximately 60,000 patient appointments daily—equivalent in capacity to nearly 100 hospitals. As one of Europe’s fastest-growing businesses, boasting a remarkable 150-fold growth over four years and surpassing $300 million in annualized revenues, this funding will enable Cera to enhance its existing AI-driven solutions and invest in new technologies that will streamline service delivery and improve patient outcomes.
Cera’s unique model has already demonstrated the ability to reduce hospitalizations by up to 70%, supported by one of the largest home healthcare datasets globally. Recognized consistently as the UK’s leading HealthTech company, Cera has garnered numerous accolades, including the Home Care Awards’ Most Outstanding Home Care Provider and the Great British Entrepreneur of the Year award in 2023. Co-founded by Dr. Ben Maruthappu MBE, a noted entrepreneur, physician, and policy expert, Cera’s commitment to providing high-quality care at a fraction of the cost is a testament to its disruptive approach. As the company embarks on this new chapter of growth, it remains dedicated to transforming how healthcare is delivered, ensuring that effective, compassionate care is accessible to all.
